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ABSTRACT
We have developed PVS (Protein Variability Server), a
web-based tool that uses several variability metrics
to compute the absolute site variability in multiple
protein-sequence alignments (MSAs). The variabil-
ity is then assigned to a user-selected reference
sequence consisting of either the first sequence in
the alignment or a consensus sequence. Subse-
quently, PVS performs tasks that are relevant for
structure-function studies, such as plotting and
visualizing the variability in a relevant 3D-structure.
Neatly, PVS also implements some other tasks
that are thought to facilitate the design of epi-
tope discovery-driven vaccines against pathogens
where sequence variability largely contributes to
immune evasion. Thus, PVS can return the con-
served fragments in the MSA—as defined by a user-
provided variability threshold—and locate them in a
relevant 3D-structure. Furthermore, PVS can return a
variability-masked sequence, which can be directly
submitted to the RANKPEP server for the prediction
of conserved T-cell epitopes. PVS is freely available
at: http://imed.med.ucm.es/PVS/.
INTRODUCTION
Multiple sequence alignments (MSAs) of homologous pro-
teins encompass unique patterns of conserved and variable
residues. The functional relevance of conserved residues is
widely acknowledged. Indeed, functionally important
residues such as those defining interacting sites, substrate
binding sites or simply relevant to protein-structure integ-
rity, display a low rate of substitution. This observation is
predicted by the neutral evolution model (1), which also
indicates that variable residues are somehow less impor-
tant. Consequently, many methods have been developed
to look for general and subfamily conservation patterns
(2–8) as a key to identify functionally important residues.
Moreover, some of these approaches are available for
public use through the web (9–11). While these methods
and related servers are very useful to identify functionally
relevant residues, they generally underestimate the var-
iability in the MSAs and certainly dismiss the significance
of variable sites.
Variable residues in proteins can however be function-
ally relevant. Indeed, sequence variability is widely used
by biological systems to generate functional heterogeneity.
Thus, the hypervariable residues in the T-cell receptors
(TCR) and Immunoglobulins match the antigen-binding
residues (12). Likewise, the most polymorphic (variable)
residues in the human leukocyte antigens (HLAs) are
located on their binding groove, explaining the distinct
peptide-binding specificities of the HLA allelic variants
(13,14). Therefore, having a direct estimate of the
sequence variability in an MSA is important to fill gaps
in structural knowledge and to offer insight for function-
structure studies. Indeed, long before the first antigen-
bound immunoglobulin crystal structures were solved
(15–17), Kabat (18) was able to anticipate that highly
variable segments in immunoglobulin molecules match
the antigen contact sites. Importantly, the estimation of
sequence variability in rapidly evolving protein antigens
from pathogens that use sequence variation for immune
evasion (19–21) provides a mean to identify conserved
antigenic determinant targets (epitopes), and consequently
it is useful for epitope-vaccine design.
For all the above, we have developed PVS, a web server
that provides absolute sequence variability estimates ‘per
site’ in an MSA as determined by the Shannon Entropy
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(22), the Simpson Diversity Index (23) and the Wu-Kabat
Variability Coefficient (18). The Wu-Kabat’s coefficient,
perhaps the most popular sequence variability metric, is
effective in resolving the highest diversity positions, but as
it has been noted, underestimates the diversity in the MSA
(24). In comparison, Shannon and Simpson methods are
statistically more sound for quantifying a system diversity,
and are widely used in ecology and sequence analyses
(25). Following the variability computations, PVS can plot
the variability in the MSA and display it in a relevant
3D-structure. PVS can also return the selected reference
sequence with the variable positions masked, as well as the
sequence fragments (minimum length selected by the user)
containing only nonvariable residues, as determined
by a user-provided variability threshold. Within the PVS
output page, the user can also locate the conserved
fragments in the provided 3D-structure, and submit the
variability-masked sequence to the RANKPEP server
(26,27) for the prediction of conserved T-cell epitopes.
Here we will show that these features are particularly
relevant for epitope discovery-driven design of vaccines
against pathogens displaying large sequence variability.
SYSTEMS AND METHODS
Automated generation ofMSAs
Automated MSAs are obtained from the protein sequence
of a Protein Data Bank (PDB) file following a BLAST (28)
search against the SWISSPROT database. The BLAST
search is performed using an E value of 1e–20 and a maxi-
mum of 250 hits are considered. Subsequently, the relevant
sequence hits are aligned using MUSCLE (29).
Computation of sequence variability
The Shannon Diversity Index (Shannon Entropy) (22),
the Simpson Diversity Index (23) and the Wu-Kabat
Variability Coefficient (30) are used to estimate the
sequence variability ‘per site’ (V ) in MSAs.
The Shannon Diversity Index (H) is given by
H ¼ "
XM
i¼1
pi log2 pi 1
where, pi is the fraction of residues of amino acid type i,
and M represents the total number of amino acid types in
a given site. H ranges from 0 (only one amino acid type is
present at that position) to 4.322 (all 20 amino acids are
equally represented in that position). Note, that for a site
including gaps the maximum value of H will be 4.39.
We estimate the Simpson Diversity Index (D) using the
following equation:
D ¼ 1"
XS
i¼1
niðni " 1Þ
NðN" 1Þ 2
where, ni is the number of residues of type i, N is the total
number of residues and S is the number of different sym-
bols ‘per site’. From Equation (2) it follows that 0%D& 1.
Those sites with D values near 1 are highly variable and
those with D values near 0 are almost constant.
The Wu-Kabat Variability Coefficient (W) is given by:
W ¼ Nk
n
3
Here, N is the number of sequences in the MSA, k is the
number of different amino acids at a given position and n
is the frequency of the most common amino acid at
that position. The minimum value of W is 1. Unlike for H
and D, W maximum value increases with the number of
sequences in the MSA.
Mapping sequence variability onto a 3D-structure
Given a relevant PDB file with the coordinates of
a 3D-structure, the V in an MSA is mapped onto the
3D-structure by simply replacing the B-factor of the
relevant residues in the PDB with the computed V values.
Implementation
PVS is implemented on an Apache Web server running
under the Mac OSX operating system. The PVS functional
core consists of a PERL CGI (Common Gateway
Interface) script that handles the input, executes several
subroutines implementing the above outlined methods,
and then assembles and displays the results. PVS uses
GNUPLOT (http://www.gnuplot.info) to plot the var-
iability and the Bioperl Bio::Graphics module (http://
www.bioperl.org) to generate sequence graphs with fea-
tures. For displaying 3D-structures, PVS uses Jmol, an
open-source Java molecular viewer for three-dimensional
chemical structures (http://www.jmol.net).
DESCRIPTION AND USAGE OF THE SERVER
Web interface
The PVS web interface will dynamically change to present
only those fields that apply to the user made selections.
This is done using JavaScript. Moreover, the web interface
is divided into the INPUT, SEQUENCE VARIABILITY
OPTIONS and OUTPUT TASKS sections which overall
facilitate an intuitive use of the server. The web interface
also provides links to help pages, and specific information
regarding the elements featured by the server can be
obtained from the question mark icons. A description
of the server usage, including the input and output
follows here.
Input and variability options
The main input data for PVS can either be (i) an MSA or
(ii) a PDB and users have to select one type or another
from the INPUT section. Once a selection is made, the
PVS web interface will show only the fields relevant to the
selected input type. Thus, for the MSA option, the user
can either paste or upload the alignment, which can be in
CLUSTALW, GCG or FASTA formats. For the PDB
input option, the user can either upload a PDB file or
supply a PDB code and PVS will retrieve the correspond-
ing PDB file from the Brookhaven database (http://
www.rcsb.org/). Next, an MSA will be built from the
sequence of the PDB chain—specified by the user—as
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detailed in ‘Systems and methods’ section. If no chain is
provided, the first chain in the PDB file will be taken by
default. Currently, PVS will only process MSAs with less
than 400 sequences and 250 000 symbols. Also, automated
MSAs will only be generated from PDB protein sequences
shorter than 400 residues. If such limits are exceeded,
the server will return an error.
Subsequently, PVS will subject the MSA to a sequence
variability analysis using several methods that can be
selected by the user from the ‘Sequence variability options’
section. The default method, ‘Shannon’, uses the Shannon
Diversity Index as the variability metric [Systems and
methods section, (Equation (1)]. Additionally, users can
also select the ‘Wu-Kabat’ Variability Coefficient [Systems
and methods, Equation (2)] and the ‘Simpson’ Diversity
Index [Systems and methods, Equation (3)].
Output
The output for PVS will be determined by the user-selected
options in the ‘Output tasks’ section. By default, PVS will
‘plot the variability’ in the MSA—computed for each
selected variability method—against a reference sequence
selected by the user (Figure 1A). The reference sequence
can either be a consensus sequence (default) or the first
sequence in theMSA. Additionally, the following tasks can
be performed by PVS: (i) ‘Mask sequence variability’;
(ii) ‘Return conserved fragments’ and (iii) ‘Map structural
variability’. The outputs and restrictions resulting from
selecting these tasks are discussed below.
Mask sequence variability. This option returns the
selected reference sequence so that those residues with V
Figure 1. PVS output. The figure shows a composition with the possible outputs of PVS. Results were obtained using an MSA corresponding to the
HIV1 glycoprotein gp120 (residues 31–183 in gp160 from HIV-1 strain H2XB2). The MSA was generated from 359 representative sequences of the
HIV-1 clades A (73), B (85), C (85), D (51) and 01_AE (65) using the program MUSCLE (29). The MSA is available at http://imed.med.ucm.es/PVS/
supplemental/gp120_aln.html. The sequence variability was computed using the ‘Shannon’, ‘Simpson’ and ‘Wu-Kabat’ methods, and from the
‘sequence variability options’, a reference ‘consensus sequence’ and the default ‘variability threshold of 1.0’ were selected. (A) ‘Variability plot’. Users
can change the variability metric (‘Shannon’, ‘Simpson’ and ‘Wu-Kabat’) by clicking on the relevant links. (B) ‘Variability masked sequence’. The
sequence is returned in FASTA and T-cell epitope predictions can be obtained by clicking on the ‘Run Epitope Prediction’ bottom. (C) ‘Conserved
fragments with no variable residues’. In this example, a ‘minimal fragment length’ of eight was selected. (D) ‘Structural variability mapping’.
Sequence variability in the alignment was mapped onto the 3D-coordinates of gp120 (chain G of PDB 1RZK). The output allows the visualization of
the variability in several user-selected renderings of the 3D structure. PVS can also display a graph of the protein sequence with the conserved
fragments shown in blue. By clicking on a fragment, the user will locate it on the 3D-structure as shown in (E) with fragment 2. The output used to
make this figure is available at: http://imed.med.ucm.es/PVS/supplemental/gp120_pvs.html.
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greater or equal than the selected variability threshold
are masked using a ‘.’ symbol. The variability-masked
sequence is returned in FASTA format (Figure 1B), and it
can be submitted to RANKPEP (26,27), the only T-cell
epitope prediction tool that can anticipate conserved
T-cell epitopes from a variability-masked sequence.
Return conserved fragments. This option identifies those
fragments (minimum length selected by user) in the
selected reference sequence consisting only of consecu-
tive residues with V below the set variability threshold
(Figure 1C). These fragments are returned, sorted in
a table by their position in the MSA. For options (i) and
(ii), the variability threshold must be between 0 and 4.3 in
the case of the Shannon Entropy and between 0 and 1 for
the Simpson Diversity Index (See Systems and methods
section), otherwise PVS will return an error message.
The default ‘variability threshold’ is 1.0 for the ‘Shannon’
Entropy method and 0.46 for the ‘Simpson’ Diversity
Index, values which are regarded as indicatives of low
variability (24). If the Shannon and Simpson methods were
selected, PVS will proceed considering the variability
threshold as for Shannon. Note that unlike the Shannon
and Simpson Diversity Index, the upper value of the
Wu-Kabat Variability Coefficient increases with the
number of sequences in theMSA (see Systems andmethods
section). Therefore, since the ‘variability threshold’ must
be entered prior to submitting the job, the options of
masking the variability and returning conserved fragments
are not available if the Wu-Kabat Variability Coefficient
is the only variability metric selected.
Map structural variability. The sequence variability in the
MSA is mapped onto a 3D-structure through a B-factor
(see Systems and methods section). If an MSA was entered
in PVS, the user must upload a relevant PDB to map the
sequence variability onto it. Obviously, if the input was
a PDB, PVS will map the sequence variability onto that
same 3D structure. Note that when the ‘Map structural
variability’ option is selected the variability is only
computed for the positions in the MSA that map with
the PDB. The resulting 3D structure is displayed using an
interactive Jmol applet (JavaScript must be enabled in the
browser) that allows the user to visualize the variability
over several structural renderings, in a color scale that
goes from blue for constant residues to red for highly
variable residues (Figure 1D). In addition, if the ‘Return
Conserved fragments’ task had also been selected, PVS
will display a graph of the protein sequence with the
conserved fragments shown in blue. By clicking on a
fragment, the user will locate it on the 3D structure
(Figure 1E).
Limitations
Proper computation of sequence variability from MSAs is
contingent on the quality of the alignments. Therefore, we
suggest evaluating the reliability of MSAs using the cor-
responding applications implemented in the TCOFFEE
web server (http://www.igs.cnrs-mrs.fr/Tcoffee/) (31). This
evaluation is particularly relevant when working with
MSAs of distantly related proteins. However, the users
should not have problems with the quality of MSAs built
from very similar sequences (e.g. allelic and antigen
variants). Likewise, we do not anticipate quality problems
on the automated MSAs generated by the server because
they are built considering only highly similar protein
sequences. Finally, while the methods implemented in PVS
are for computing sequence variability from MSAs, other
methods do exist that can estimate sequence variability
without the need of an MSA (32–34).
COMPARISON WITH AVAILABLE SERVERS
Sequence variability or conservation analyses, particularly
when combined with mapping the variability onto a
relevant 3D-structure, are useful to explore structure–
function relationships and to reveal functionally relevant
residues. Not surprisingly, some servers are already avail-
able (summarized in Table 1) that given an MSA can
perform related tasks, such as providing a consensus
sequence as ‘Consensus’, or plotting the relative sequence
variability as in ‘WebVar’ (35). Other servers such as
‘Conseq’ and ‘TreeDet’ (20) carry out sophisticated conser-
vation analyses to identify functionally relevant residues,
and ‘Consurf’ (20), using the same phylogeny-dependent
algorithms as ‘Conseq’ (9), maps the conservation scores
onto a relevant 3D-structure. The ‘Conservancy’ (36)
server is another related tool that from a set of user-
provided predefined epitopes, identifies their conservation
as determined by a percentage of identity. In comparison,
PVS can handle more input types (PDBs or MSAs) and
formats (MSAs can be in FASTA, CLUSTAW and GCG)
that most of the related servers, and offers the largest set of
functional tasks (Table 1). In any case, despite all these
servers being related to some extent, they differ with regard
to their methods and specific objectives, and indeed PVS is
unique for using sequence variability analyses to help with
epitope-vaccine design.
PVS RELEVANCE FOR EPITOPE DISCOVERY:
WORKED EXAMPLES
Sequence variability analyses are commonly applied to
infer evolutive and functional information in systems
where functional diversity is achieved through sequence
variation. For example, we previously applied a sequence
variability analysis to human class I and class II MHC
molecules (13), which, when correlated with the available
structural information, clearly showed that the majority of
the polymorphisms exhibited by these molecules are
related with their differential peptide-binding specificity.
In addition, we could also identify some other poly-
morphisms that could determine the restriction by their
cognate T-cell receptors. While these classic structure–
function studies can be carried in PVS, we will focus here
on illustrating the use of PVS in the context of epitope-
vaccine design.
PVS results are in fact tuned to facilitate the design of
vaccines driven by epitope discovery against pathogenic
organisms such as HIV-1, where sequence variation
largely contributes to immune evasion, and sequence
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variability analyses are needed to identify conserved
epitopes (37). The discovery of conserved T-cell epitopes
(antigenic peptides recognized by the T cells when bound
and displayed by MHC molecules in the cell surface of
target cells) is facilitated in PVS by providing variability-
masked sequences that can be submitted directly to the
RANKPEP web server. Subsequently, RANKPEP will
only return predicted conserved T-cell epitopes, thus also
reducing the number of T-cell epitopes that have to be
considered for experimental epitope confirmation. For
example, from the gp120 variability masked sequence
shown in Figure 1, RANKPEP will return two conserved
T-cell epitopes restricted by the HLA I molecule A'0201
(KLTPLCVTL and PVVSTQLLL) as judged by their
above-threshold binding score to A'0201 and by the
predicted proteasomal cleavage. These predictions can be
obtained from the gp120 PVS result page at: http://
imed.med.ucm.es/PVS/supplemental/gp120_pvs.html. In
comparison, the corresponding gp120 sequence of HIV-1
H2XB2 strain will yield 10 epitopes, a 5-fold increase in
the epitope number (data not shown). Therefore, regard-
less of the predictive power of RANKPEP, this strategy
saves the time, effort and resources one would need to
consume confirming nonconserved T-cell epitopes that are
not as suitable for vaccine design.
PVS results can also be helpful for the identification of
conserved B-cell epitopes, the antigenic determinants of
antibodies (Abs). As an example, we were able to detect
seven highly conserved fragments of six or more residues
(Table 2) from an MSA of the ectodomain of HIV-1 gp41
(details in Table 2 legend), which is the target of various
broadly neutralizing Abs (38). Interestingly, fragments 5
and 7 encompass the antigenic determinants (B-cell
epitopes) of the monoclonal antibodies CL3 and ZE10,
respectively, both broadly neutralizing (38). Abs, however,
only recognize solvent-exposed epitopes and most of them
are conformational but can also be linear. Consequently,
when used as immunogens, the majority of these
conserved fragments will fail to yield Abs cross-reacting
with the native antigen. However, one can also use PVS to
locate the conserved fragments in the 3D-structure (when
available), and select those that are surface exposed.
Under such scenario, the chance of producing Abs that are
cross-reactive with the native antigen and broadly
neutralizing will be greatly increased. For example, in
Figure 1E we have chosen to display the conserved
fragment 2 (ITQACPKVSF) from HIV-1 gp120, which is
readily accessible to the solvent. Moreover, from the PVS
results obtained from the gp120 MSA (http://imed.med.
ucm.es/PVS/supplemental/gp120_pvs.html) one could
Table 1. Web servers related to PVS
Web server Input: formats Output and tasks Ref
( PVS
http://imed.med.ucm.es/PVS/
( MSA: CLUSTAL, FASTA, GCG/MSF
( PDB: Uploaded or retrieved
( MSA and PDB
1. Compute sequence variability
2. Plot sequence variability
3. Map and display variability
in 3D structures
4. Mask sequence variability
5. T-cell epitope prediction
6. Return conserved fragments
7. Locate conserved fragments
into 3D structures/B-cell
epitope prediction
( SVS'
http://bio.dfci.harvard.edu/Tools/svs.html
( MSA: CLUSTAL 1. Compute sequence variability
as given by Shannon Entropy
2. Plot sequence variability
3. Return conserved fragments
( SiteVarProt
http://159.149.109.16/Tools/SiteVarProt.php
( MSA: FASTA 1. Compute relative
sequence variability
2. Plot sequence variability
(35)
( Consensus
http://coot.embl.de/Alignment//consensus.html
( MSA: CLUSTAL and GCG/MSF 1. Consensus sequence at
various thresholds with
amino acid groupings
( Conseq http://conseq.bioinfo.tau.ac.il/ ( SEQUENCE: FASTA
( MSA: NBRF/PIR, EMB, FASTA, GDE,
CLUSTAL, GCG/MSF and RSF
1. Compute conservation scores
2. Compute solvent accessibility
3. Return color-coded sequence
with calculations
(9)
( Consurf http://consurf.tau.ac.il/ ( PDB: Uploaded or retrieved
( MSA and PDB
1. Compute conservation scores
2. Map and display conservation
scores in 3D structures
(11)
( TreeDet
http://www.pdg.cnb.uam.es/Servers/treedet/
( MSA: CLUSTAL, FASTA, MSF and PIR ( Predicts and display
functionally relevant
residues
(10)
( Conservancy
http://tools.immuneepitope.org/tools/conservancy
( SEQUENCES: FASTA ( Computes per site sequence
identity of epitopes in
protein sources
(36)
PVS is an enhanced version of SVS, a server previously developed by Dr Reche. SVS has >85 000 hits since it started running in 2002.
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also see that fragment 3 and significant portions of
fragments 1, 4 and 6 are also accessible to the solvent.
CONCLUSIONS AND FUTURE DIRECTIONS
PVS is a user-friendly and versatile web server where
sequence variability computations are exploited to facil-
itate structure-function studies and, unlike any other
related server, de novo epitope discovery. In the future, we
plan to include additional variability and conservation
scores. Moreover, we will implement solvent accessibility
calculations, which should enhance the potential of PVS in
structure–function studies and B-cell epitope discovery.
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